三菱ケミカル株式会社、世界にまたがる知財の管理に アナクアのAQXプラットフォームを採用
July 17, 2024 19:00 ET
|
Anaqua
ボストン, July 18, 2024 (GLOBE NEWSWIRE) --...
Mitsubishi Chemical Selects Anaqua’s AQX Platform for Global IP Management
July 17, 2024 19:00 ET
|
Anaqua
Mitsubishi Chemical Corporation selects Anaqua’s AQX® IP management platform to help coordinate and optimize the management of their Intellectual Property.
CBIH Charts Path to Future Leadership in Cannabis Medicine
July 08, 2024 08:00 ET
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
A letter from our desk HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Since the start of the year, Cannabis Bioscience International Holdings (OTCMKTS: CBIH) has embarked on a transformative journey...
Medsenic, filiale de BioSenic SA, étend un brevet clé aux États-Unis
July 05, 2024 01:00 ET
|
BioSenic
COMMUNIQUE DE PRESSE – INFORMATION PRIVILEGIEE Une famille de brevets récents en cours de développement par Medsenic couvre l'utilisation thérapeutique de sels d'arsenic et d’ions métalliques par...
Medsenic, subsidiary of BioSenic SA, extends key patent to the United States
July 05, 2024 01:00 ET
|
BioSenic
PRESS RELEASE – PRIVILEGED INFORMATION The developed Medsenic’s composition-of-matter patent family does cover the therapeutic use of arsenic salts and metal ions through various routes of...
InterDigital signs license agreement with Google
July 02, 2024 04:00 ET
|
InterDigital, Inc.
InterDigital signed a new license agreement with Google to license InterDigital's cellular wireless, Wi-Fi, and HEVC video patented technologies
CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers
July 01, 2024 08:00 ET
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is excited to announce the submission of our inaugural pair of patents, focusing on novel treatm
Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment
June 28, 2024 07:55 ET
|
Clearmind Medicine Inc.
Vancouver, Canada, June 28, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...
Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions
June 26, 2024 09:15 ET
|
Cyclacel
NOTICE OF INTENTION TO GRANT OF NEW EUROPEAN PATENT
COVERING PLOGOSERTIB PHARMACEUTICAL COMPOSITIONS
- Lengthens Patent Exclusivity to August 2040
アナクアがAI活用機能などを含む知財管理プラットフォームの新バージョン AQX® 11をリリース
June 26, 2024 08:00 ET
|
Anaqua
ボストン, June 26, 2024 (GLOBE NEWSWIRE) -- 知的財産管理とイノベーション管理ソリューションの業界トップクラスのテクノロジープロバイダーである米国アナクア社（Anaqua）が、AIを活用した管理システムの新バージョン AQX®...